Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Solary

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Cell Death and Differentiation|June 3, 2017
NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapyQiuji Wu, Awatef Allouch, Audrey Paoletti, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Communications Biology|February 4, 2022
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytesElodie Pronier, Aygun Imanci, Dorothée Selimoglu-Buet, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
JCI Insight|March 30, 2017
Serum Gp96 is a chaperone of complement-C3 during graft-versus-host diseaseAntoine Seignez, Anne-Laure Joly, Killian Chaumonnot, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Blood|April 9, 2015
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaDorothée Selimoglu-Buet, Orianne Wagner-Ballon, Véronique Saada, et al.
International Journal of Molecular Sciences|February 25, 2023
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged TissuesStéphanie Solier, Michele Mondini, Lydia Meziani, et al.
Autophagy|June 2, 2015
The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMMLSandrine Obba, Zoheir Hizir, Laurent Boyer, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Cell Death and Differentiation|June 3, 2017
NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapyQiuji Wu, Awatef Allouch, Audrey Paoletti, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Communications Biology|February 4, 2022
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytesElodie Pronier, Aygun Imanci, Dorothée Selimoglu-Buet, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
JCI Insight|March 30, 2017
Serum Gp96 is a chaperone of complement-C3 during graft-versus-host diseaseAntoine Seignez, Anne-Laure Joly, Killian Chaumonnot, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Blood|April 9, 2015
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaDorothée Selimoglu-Buet, Orianne Wagner-Ballon, Véronique Saada, et al.
International Journal of Molecular Sciences|February 25, 2023
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged TissuesStéphanie Solier, Michele Mondini, Lydia Meziani, et al.
Autophagy|June 2, 2015
The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMMLSandrine Obba, Zoheir Hizir, Laurent Boyer, et al.
Pageof 28